Skip to content
naulon
Not checkedNot checked for notices yet.

Exosome derived from stem cell: A promising therapeutics for wound healing

Hui Lv, Hanxiao Liu, Ting Sun and 3 more

Frontiers in Pharmacology · 2022

doi:10.3389/fphar.2022.957771 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

A wound occurs when the epidermis and dermis of the skin are damaged internally and externally. The traditional wound healing method is unsatisfactory, which will prolong the treatment time and increase the treatment cost, which brings economic and psychological burdens to patients. Therefore, there is an urgent need for a new method to accelerate wound healing. As a cell-free therapy, exosome derived from stem cell (EdSC) offers new possibilities for wound healing. EdSC is the smallest extracellular vesicle secreted by stem cells with diameters of 30–150 nm and a lipid bilayer structure. Previous studies have found that EdSC can participate in and promote almost all stages of wound healing, including regulating inflammatory cells; improving activation of fibroblasts, keratinocytes, and endothelial cells; and adjusting the ratio of collagen Ⅰ and Ⅲ. We reviewed the relevant knowledge of wounds; summarized the biogenesis, isolation, and identification of exosomes; and clarified the pharmacological role of exosomes in promoting wound healing. This review provides knowledge support for the pharmacological study of exosomes.

Abstract licence: CC BY

References159

  1. 2.
  2. 7.
  3. 8.
  4. 9.
  5. 16.
  6. 24.
  7. 27.
  8. 30.
  9. 34.
  10. 37.
  11. 40.

29 more references, whose wording the paper’s licence keeps private.

All 159 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.